Radio World2d
DNAV and SAS Team Up for Transmission Router
DNAV has released a new transmission router from Sierra Automated Systems (SAS), which the companies will demonstrate at the ...
MyChesCo on MSN17h
Lungpacer Medical Secures FDA Approval for AHRF Trial
Lungpacer Medical has announced that the U.S. Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) for the STARI (STimulation to Activate RespIration) clinical ...
Lungpacer Medical Announces Investigational Device Exemption (IDE) for STARI, Phase 2 Feasibility Clinical Trial
The investigational AeroNova® System delivers continual diaphragm neurostimulation in conjunction with mechanical ventilation ...
MassDevice3d
Lungpacer wins FDA IDE for AeroNova system
Lungpacer Medical announced that it received FDA investigational device exemption (IDE) approval to begin a trial for its ...
Morningstar3d
Lungpacer Medical Announces Investigational Device Exemption (IDE) for STARI, Phase 2 Feasibility Clinical Trial
The STARI trial (NCT06832306), a Phase 2 feasibility study, will explore the potential of transvenous diaphragm neurostimulation-assisted ventilation (DNAV) in mechanically ventilated patients ...